✦ LIBER ✦

CN2 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF STAGE III COLON CANCER IN TAIWAN

✍ Scribed by TC Hsu; HH Chen; LT Chen; CR Changchien; MC Liu; HM Wang; L Yang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacoeconomic Analysis of Capecitabin

✍ Tzu-Chi Hsu; Hong-Hwa Chen; Ming-Chin Yang; Hwei-Ming Wang; Jye-Hann Chuang; Shu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

PCN22 IS CAPECITABINE A COST-EFFECTIVE A

✍ MC Orchard; J Hoch; SMH Alibhai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

CN2 A SYSTEMATIC REVIEW AND META-ANALYSI

✍ Lerdkiattikorn, P; Chaikledkaew, U; Kingkaew, P; Teerawattananon, Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

CN1 COST-EFFECTIVENESS ANALYSIS OF OXALI

✍ S Aballea; J Chancellor; M Raikou; M Drummond; R Diel; M Frick; S Rosenfeld; A B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Pharmacoeconomic analysis of adjuvant or

✍ Cassidy, J; Douillard, J-Y; Twelves, C; McKendrick, J J; Scheithauer, W; Bustová 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Current Issues in Adjuvant Treatment of

✍ Thierry André; Daniel Sargent; Josep Tabernero; Michael O’Connell; Marc Buyse; A 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 148 KB